Terminated PHASE2 INTERVENTIONAL 2-arm NCT02790957

Plerixafor in Diabetic Wound Healing (MOZOBL07740)

Effect of a Single Plerixafor Injection on Diabetic Wound Healing. A Pilot, Double-blind, Placebo-controlled, Randomized Trial

Sponsor: Gian Paolo Fadini

Conditions Critical Limb Ischemia Diabetes Wounds

Interventions Placebo Plerixafor

Updated 7 times since 2017 Last updated: Dec 17, 2019 Started: Jun 30, 2016 Primary completion: Aug 31, 2019 Completion: Nov 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Safety reasons

This PHASE2 trial investigates Critical Limb Ischemia and Diabetes and is currently terminated or withdrawn. Gian Paolo Fadini leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2020 — Jan 2021 [monthly]

Terminated PHASE2

Status: Recruiting → Terminated

▶ Show 2 earlier versions

Jun 2018 — Jan 2020 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gian Paolo Fadini
University Hospital Padova

Data source: University of Padova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Padua, Italy